Circ_0092367 Inhibits EMT and Gemcitabine Resistance in Pancreatic Cancer via Regulating the miR-1206/ESRP1 Axis

Gemcitabine is the first-line treatment for patients with pancreatic cancer (PC), yet most patients develop resistance to gemcitabine. Recent studies showed that circular RNAs (circRNAs) have important regulatory roles in PC progression and chemoresistance. In this study, the ability of circRNA circ...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Shuo Yu, Min Wang, Hang Zhang, Xingjun Guo, Renyi Qin
Formato: article
Lenguaje:EN
Publicado: MDPI AG 2021
Materias:
EMT
Acceso en línea:https://doaj.org/article/aa3cb364678e4a638dbe266b8aa7f540
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!